Glial cell line-derived neurotrophic factor enhances human islet posttransplantation survival.
Glial cell line-derived neurotrophic factor enhances human islet posttransplantation survival.
复制标题
DOI:
10.1097/tp.0b013e31822bc95a
复制
发表时间:
2011-10-15
期刊:
影响因子:
6.2
通讯作者:
Srinivasan S
中科院分区:
文献类型:
--
作者:
Mwangi SM;Usta Y;Shahnavaz N;Joseph I;Avila J;Cano J;Chetty VK;Larsen CP;Sitaraman SV;Srinivasan S
Development of pre-transplantation islet culture strategies that preserve or enhance β-cell viability would eliminate the requirement for the large numbers of islets needed to restore insulin independence in type 1 diabetes patients. We investigated whether glial cell line-derived neurotrophic factor (GDNF) could improve human islet survival and post-transplantation function in diabetic mice. Human islets were cultured in medium supplemented with or without GDNF (100 ng/ml) and in vitro islet survival and function assessed by analyzing β-cell apoptosis and glucose stimulated insulin release. In vivo effects of GDNF were assessed in streptozotocin-induced diabetic nude mice transplanted under the kidney capsule with 2000 islet equivalents of human islets pre-cultured in medium supplemented with or without GDNF. In vitro, human islets cultured for 2–10 days in medium supplemented with GDNF showed lower β-cell death, increased Akt phosphorylation and higher glucose-induced insulin secretion than islets cultured in vehicle. Human islets pre-cultured in medium supplemented with GDNF restored more diabetic mice to normoglycemia and for a longer period after transplantation than islets cultured in vehicle. Our study shows that GDNF has beneficial effects on human islet survival and could be used to improve islet post-transplantation survival.